Helicobacter pylori: the size of the problem.
作者信息
Parsonnet J
机构信息
Stanford University, CA 94305-5405, USA.
出版信息
Gut. 1998 Jul;43 Suppl 1(Suppl 1):S6-9. doi: 10.1136/gut.43.2008.s6.
Abstract
摘要
相似文献
1
Helicobacter pylori: the size of the problem.幽门螺杆菌：问题的严重程度
Gut. 1998 Jul;43 Suppl 1(Suppl 1):S6-9. doi: 10.1136/gut.43.2008.s6.
2
Helicobacter pylori and duodenal ulcer. Evidence suggesting causation.幽门螺杆菌与十二指肠溃疡。提示因果关系的证据。
Dig Dis Sci. 1992 May;37(5):769-72. doi: 10.1007/BF01296437.
3
Helicobacter pylori: the African enigma.幽门螺杆菌：非洲之谜。
Gut. 1992 Apr;33(4):429-31. doi: 10.1136/gut.33.4.429.
4
Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era.幽门螺杆菌是人类胃部的原生菌：十二指肠溃疡是现代时期胃微生态变化所致。
Gut. 1998 Nov;43(5):721-7. doi: 10.1136/gut.43.5.721.
5
H. pylori and gastroduodenal disease.幽门螺杆菌与胃十二指肠疾病。
Practitioner. 1991 Oct;235(1507):733-6.
6
The presence of dupA in Helicobacter pylori is not significantly associated with duodenal ulceration in Belgium, South Africa, China, or North America.在比利时、南非、中国或北美，幽门螺杆菌中dupA的存在与十二指肠溃疡并无显著关联。
Clin Infect Dis. 2007 Nov 1;45(9):1204-6. doi: 10.1086/522177. Epub 2007 Sep 21.
7
[Helicobacter pylori and duodenal ulcer: a causal relation or mere association?].[幽门螺杆菌与十二指肠溃疡：因果关系还是单纯关联？]
Rev Clin Esp. 1997 Oct;197(10):693-702.
8
9
The epidemiology of Helicobacter pylori: where to from here?幽门螺杆菌的流行病学：路在何方？
J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):7-8. doi: 10.1097/00005176-200301000-00004.
10
Pathological consequences of Helicobacter pylori infection.幽门螺杆菌感染的病理后果。
Scand J Gastroenterol Suppl. 1996;215:21.
引用本文的文献
1
A collection of the etiological theories, characteristics, and observations/phenomena of peptic ulcers in existing data.现有数据中关于消化性溃疡的病因理论、特征以及观察结果/现象的汇总。
Data Brief. 2018 May 16;19:1058-1067. doi: 10.1016/j.dib.2018.05.022. eCollection 2018 Aug.
2
Inhibition of Growth by Redox Cycling Phenylaminojuglones.醌式氨基胡桃醌的氧化还原循环抑制生长。
Oxid Med Cell Longev. 2018 Apr 24;2018:1618051. doi: 10.1155/2018/1618051. eCollection 2018.
3
Isolation of Abscisic Acid from Korean Acacia Honey with Anti- Activity.从具有抗活性的韩国相思树蜂蜜中分离脱落酸。
Pharmacogn Mag. 2017 Jul;13(Suppl 2):S170-S173. doi: 10.4103/0973-1296.210166. Epub 2017 Jul 11.
4
Analysis of Gastric Body Microbiota by Pyrosequencing: Possible Role of Bacteria Other Than in the Gastric Carcinogenesis.焦磷酸测序法分析胃体微生物群：除幽门螺杆菌外的细菌在胃癌发生中的可能作用
J Cancer Prev. 2017 Jun;22(2):115-125. doi: 10.15430/JCP.2017.22.2.115. Epub 2017 Jun 30.
5
An In Silico Approach for Identification of the Pathogenic Species, Helicobacter pylori and Its Relatives.一种用于鉴定致病物种幽门螺杆菌及其相关菌的计算机模拟方法。
Indian J Microbiol. 2016 Sep;56(3):277-86. doi: 10.1007/s12088-016-0575-7. Epub 2016 Apr 30.
6
Piperine treatment suppresses Helicobacter pylori toxin entry in to gastric epithelium and minimizes β-catenin mediated oncogenesis and IL-8 secretion in vitro.胡椒碱处理可抑制幽门螺杆菌毒素进入胃上皮细胞，并在体外将β-连环蛋白介导的肿瘤发生和白细胞介素-8分泌降至最低。
Am J Transl Res. 2016 Feb 15;8(2):885-98. eCollection 2016.
7
Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats.余甘子果实提取物减轻幽门螺杆菌脂多糖诱导的Sprague Dawley大鼠氧化应激。
BMC Complement Altern Med. 2015 Oct 19;15:375. doi: 10.1186/s12906-015-0915-x.
8
Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences.来自多个中心的幽门螺杆菌集中分离及运输条件的影响。
World J Gastroenterol. 2015 Jan 21;21(3):944-52. doi: 10.3748/wjg.v21.i3.944.
9
Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.日本 10837 例患者反流性食管炎和非糜烂性反流病的背景因素：一项横断面研究。
PLoS One. 2013 Jul 26;8(7):e69891. doi: 10.1371/journal.pone.0069891. Print 2013.
10
Lactic acid bacterial extracts as anti-Helicobacter pylori: a molecular approach.乳酸菌提取物抗幽门螺杆菌：分子方法。
Ir J Med Sci. 2013 Sep;182(3):439-52. doi: 10.1007/s11845-013-0909-y. Epub 2013 Feb 13.
本文引用的文献
1
Cancer and infection: estimates of the attributable fraction in 1990.癌症与感染：1990年归因分数的估计值。
Cancer Epidemiol Biomarkers Prev. 1997 Jun;6(6):387-400.
2
The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled.智障机构居民和健康员工中幽门螺杆菌感染的患病率
Am J Gastroenterol. 1997 Jun;92(6):1000-4.
3
Helicobacter pylori eradication and its implications for the future.幽门螺杆菌根除及其对未来的影响。
Aliment Pharmacol Ther. 1997 Apr;11 Suppl 1:103-7. doi: 10.1046/j.1365-2036.11.s1.7.x.
4
Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?幽门螺杆菌、高氨血症与肝性脑病：它们之间存在关联吗？
Am J Gastroenterol. 1997 Apr;92(4):723-4.
5
Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.消化性溃疡危险因素的Meta分析。非甾体抗炎药、幽门螺杆菌与吸烟。
J Clin Gastroenterol. 1997 Jan;24(1):2-17. doi: 10.1097/00004836-199701000-00002.
6
Eradication of Helicobacter pylori as the only successful treatment in rosacea.根除幽门螺杆菌是酒渣鼻唯一成功的治疗方法。
Arch Dermatol. 1996 Nov;132(11):1393.
7
Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study.幽门螺杆菌根除与功能性消化不良的长期结局：一项临床内镜研究
Dig Dis Sci. 1996 Aug;41(8):1589-94. doi: 10.1007/BF02087905.
8
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways.哥伦比亚安第斯地区的幽门螺杆菌感染：一项基于人群的传播途径研究。
Am J Epidemiol. 1996 Aug 1;144(3):290-9. doi: 10.1093/oxfordjournals.aje.a008924.
9
The incidence of Helicobacter pylori infection.幽门螺杆菌感染的发病率。
Aliment Pharmacol Ther. 1995;9 Suppl 2:45-51.
10
Temporal trends and geographical variations of peptic ulcer disease.消化性溃疡疾病的时间趋势和地理差异
Aliment Pharmacol Ther. 1995;9 Suppl 2:3-12.
Zotero 插件